Correction: Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study.

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC5992370 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature